Tiziana Life Sciences
Quarterly Financials
| Values in thousands | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|
Cash | 1,183 | 1,183 | 1,183 | 6,597 |
Basic Shares | 100,307 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -51 | -141 | -89 | |
EBITDA | -15,339 | -26,340 | -32,168 | |
EBIT | -15,390 | -26,481 | -32,259 | |
Net Income | -17,691 | -16,208 | -23,417 | -27,730 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -15,698 | -19,615 | -21,784 | -12,805 |
Cash | 1,183 | 18,122 | 42,186 | 65,711 |
Basic Shares | 101,526 | 97,932 | 169,065 |
Earnings Calls
| Quarter | EPS |
|---|---|
2022-09-30 | -$0.05 |
2022-03-31 | -$0.24 |
2021-09-30 | $0 |
2021-06-30 | -$0.08 |
